Interleukin‐18 as a target for modulation of irinotecan‐induced intestinal toxicity: a step towards a better therapeutic index?: Commentary on Lima‐Junior et al., Br J Pharmacol 171: 2335–2350

Publisher: John Wiley & Sons Inc

E-ISSN: 1476-5381|172|19|4779-4781

ISSN: 0007-1188

Source: BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.19, 2015-10, pp. : 4779-4781

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content